- Home
- ELME vs NVCR Comparison
ELME vs NVCR Comparison
Compare ELME & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELME
- NVCR
- Stock Information
- Founded
- ELME 1960
- NVCR 2000
- Country
- ELME United States
- NVCR Switzerland
- Employees
- ELME N/A
- NVCR N/A
- Industry
- ELME Real Estate Investment Trusts
- NVCR Medical/Dental Instruments
- Sector
- ELME Real Estate
- NVCR Health Care
- Exchange
- ELME Nasdaq
- NVCR Nasdaq
- Market Cap
- ELME 1.4B
- NVCR 1.4B
- IPO Year
- ELME N/A
- NVCR 2015
- Fundamental
- Price
- ELME $17.22
- NVCR $12.28
- Analyst Decision
- ELME Hold
- NVCR Buy
- Analyst Count
- ELME 6
- NVCR 7
- Target Price
- ELME $18.20
- NVCR $28.79
- AVG Volume (30 Days)
- ELME 974.9K
- NVCR 1.3M
- Earning Date
- ELME 11-03-2025
- NVCR 10-29-2025
- Dividend Yield
- ELME 4.20%
- NVCR N/A
- EPS Growth
- ELME N/A
- NVCR N/A
- EPS
- ELME N/A
- NVCR N/A
- Revenue
- ELME $245,911,000.00
- NVCR $630,160,000.00
- Revenue This Year
- ELME N/A
- NVCR $6.68
- Revenue Next Year
- ELME $6.20
- NVCR $7.01
- P/E Ratio
- ELME N/A
- NVCR N/A
- Revenue Growth
- ELME 4.59
- NVCR 14.58
- 52 Week Low
- ELME $13.95
- NVCR $10.87
- 52 Week High
- ELME $18.49
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- ELME 66.25
- NVCR 48.06
- Support Level
- ELME $16.86
- NVCR $11.71
- Resistance Level
- ELME $17.24
- NVCR $12.50
- Average True Range (ATR)
- ELME 0.18
- NVCR 0.45
- MACD
- ELME 0.01
- NVCR 0.20
- Stochastic Oscillator
- ELME 93.33
- NVCR 77.25
About ELME Elme Communities
Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.